Stratford Consulting’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Stratford Consulting's BMY Position: Q1 2020 in Review
Stratford Consulting sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 3,322 shares — an estimated $213K sold.
Stratford Consulting first reported a position in BMY in Q2 2013 and held it in 15 quarters. The position peaked at $522K in Q1 2015. 2,147 funds tracked by Wall St. Rank hold BMY as of Q1 2020.
- Stratford Consulting reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
- Stratford Consulting sold 3,322 Bristol-Myers Squibb shares in Q1 2020, an estimated $213K.
- Stratford Consulting first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 15 quarters.
- Stratford Consulting's Bristol-Myers Squibb position peaked at $522K in Q1 2015.
- 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.
Based on Stratford Consulting's 13F filing for Q1 2020, filed 11 May 2020.